Box 1: Eligibility criteria for PrEP reimbursement in Belgium (issued by the National institute for Health and Disability Insurance as of June 1, 2017).

Source: Rijksinstituut voor ziekte – en invaliditeitsverzekering ( http://www.inami.fgov.be/nl/themas/kost-terugbetaling/door-ziekenfonds/geneesmiddel-gezondheidsproduct/terugbetalen/specialiteiten/wijzigingen/Paginas/geneesmiddelen-PrEp-HIV.aspx#.WqErna0zU3E ).

Verfasser: Veerle Buffel (9735811)
Caroline Masquillier (315709)
Thijs Reyniers (3907240)
Ella Van Landeghem (9194835)
Edwin Wouters (275864)
Bea Vuylsteke (330524)
Christiana Nöstlinger (315713)
Dokumenttyp: Image
Erscheinungsdatum: 2021
Schlagwörter: Biotechnology / Evolutionary Biology / Developmental Biology / Cancer / Science Policy / Infectious Diseases / Computational Biology / Environmental Sciences not elsewhere classified / Sub-Saharan / PrEP use / PrEP users / Belgian PrEP eligibility criteria / HIV risk factors
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-26525462
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.1371/journal.pone.0256269.g001